Cystic fibrosis
An inherited condition that makes the body produce thick, sticky mucus, which can affect the lungs and the digestive system. Common signs are a lasting cough with mucus, frequent chest infections and, in children, slow growth. There is no cure yet, but medicines, physiotherapy and diet support can help. A child gets it only when both parents pass on the altered gene, and many people diagnosed today are expected to live well past middle age.
Read more about cystic fibrosisTrial-stage treatments and research studies you can joinOpen trials for referral
Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.
Filters
- Tests inhaled SPL84 in adults with cystic fibrosis and a specific gene mutation
Tests whether inhaled SPL84 is safe and may help adults with cystic fibrosis.
Barcelona, SpainAge 18+ - Tests galvokimig against placebo in adults with non-cystic fibrosis bronchiectasis
Tests galvokimig against placebo in adults with bronchiectasis to see whether it delays flare-ups.
Barcelona, SpainAlso Oviedo, Palma, Santiago de Compostela, ValenciaAge 18 to 80 - Tests inhaled ensifentrine for non-cystic fibrosis bronchiectasis
Compares inhaled ensifentrine with placebo in adults with bronchiectasis.
A Coruña, SpainAlso Barcelona, Huelva, L'hospitalet De Llobregat, Lleida, Madrid, Oviedo, Pamplona, Pozuelo de AlarcónAge 18 to 80 - Tests inhaled CSL787 in adults with non-cystic fibrosis bronchiectasis
Tests an inhaled antibody treatment against placebo in adults with bronchiectasis.
Barcelona, SpainAlso Girona, Lleida, Logroño, Pozuelo de Alarcón, Sant Boi de Llobregat, Santiago de Compostela, ValladolidAge 18 to 85 - New Pancreatic Enzyme Capsule NHS7108 for Adults With Exocrine Pancreatic Insufficiency
Tests the new lipase NHS7108 against Zenpep in adults with exocrine pancreatic insufficiency.
Lleida, SpainAlso Madrid, Málaga, Murcia, ValenciaAge 18 to 85 - Comparing Ways to Collect Germ Samples in Children With Chronic Lung Disease
Compares throat suction with other samples in children with cystic fibrosis or bronchiectasis.
Sabadell, SpainAge 5 to 18 - Tests inhaled SPL84 for safety in people with cystic fibrosis
Tests an inhaled medicine, SPL84, for safety in adults with cystic fibrosis.
Barcelona, SpainAge 18+ - VX-828 and deutivacaftor, with or without tezacaftor, in adults with cystic fibrosis
Tests VX-828 with deutivacaftor, with or without tezacaftor, in adults with cystic fibrosis.
Barcelona, SpainAlso Madrid, Murcia, ValenciaAge 18+ - Measuring Thigh and Grip Strength in Adults Across Southern Europe
Measures thigh and hand strength in healthy adults and people with lung disease.
Alcalá de Henares, SpainAge 18 to 89 - Tests game-style phone apps for airway clearance in children with cystic fibrosis
Tests game-based phone apps for clearing airways in children and teens with cystic fibrosis.
Seville, SpainAge 8 to 20 - Online Monitoring Program to Prevent Flare-Ups in Cystic Fibrosis
Tests an online monitoring program to spot flare-ups early in people with cystic fibrosis.
Valencia, SpainAge 6+
Trials that have ended are not listed here, because nobody can join them. Stopped and finished Cystic fibrosis trials (research view)
Take part in research
16 official research programmes take people with this disease. In a biobank or a registry you give a blood or tissue sample, or your health data, for many research teams to use.
See the research programmesSearch the publications
The results open on the publications page in a new tab, so this page stays as it is.
Lists with this disease filtered
Where treatment stands
There is no cure yet, but treatment can often manage the symptoms, and many people diagnosed today will live well past middle age.
Approved: 22
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 4
Being tested in people. Many treatments at this stage are never approved.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 19 other open phase 2 trials are not listed.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. EU approvals newer than that data come from the European Commission’s Union Register, checked on 17 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Spain, for you and your family.
Cystic fibrosis organisations in Spain
- A tot pulmó
Non-profit association of patients, caregivers and professionals interested in respiratory diseases in Spain.
- Federación Española de Asociaciones de Pacientes Alérgicos y con Enfermedades Respiratorias (FENAER)
Federation of allergy and respiratory patient associations, with COPD, asthma and bronchiectasis coordinators and groups.
- Fundació Respiralia
Respiralia group and foundation, a Spanish reference organisation for cystic fibrosis.
- Fundación Lovexair
Spanish foundation serving respiratory health, supporting patients with chronic respiratory diseases.
General support in Spain
- Línea 024 de atención a la conducta suicida
Spain's free 24/7 national helpline 024 of the Ministry of Health for people with suicidal thoughts and their relatives.
- Teléfono de la Esperanza
Spanish non-profit offering a free, confidential crisis and emotional support line and mental health promotion across Spain.
International organisations
Frontlight Community
Cystic fibrosis community in Spain
People living with cystic fibrosis and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.
You need a Frontlight account with a verified e-mail address to comment.
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
23 medicines are approved for cystic fibrosis in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. The French ratings are the opinions of the HAS Transparency Committee, from the French public medicines database (base de données publique des médicaments, newest opinion 10 Dec 2025). 2 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
About cystic fibrosis
Sources: NHS, MedlinePlus, Journal of Cystic Fibrosis
An inherited condition that makes the body produce thick, sticky mucus, which can affect the lungs and the digestive system. Common signs are a lasting cough with mucus, frequent chest infections and, in children, slow growth. There is no cure yet, but medicines, physiotherapy and diet support can help. A child gets it only when both parents pass on the altered gene, and many people diagnosed today are expected to live well past middle age.
What is it?
Cystic fibrosis (CF) is a rare inherited condition. The body makes thick, sticky mucus that can affect the lungs and the digestive system and makes infections more likely. It mostly affects the lungs, the pancreas, the liver, the gut, the sinuses and the sex organs.
A child gets CF only when both parents pass on an altered gene. Someone who gets the gene from just one parent usually has no symptoms but is a carrier. When two carriers have a child, there is a 1 in 4 chance that the child has CF. If you have CF or are a carrier, you can ask for genetic counselling before having a baby.
The first signs
Most babies are now found through newborn screening.
- a cough that does not go away and brings up mucus;
- wheezing and shortness of breath;
- frequent chest and sinus infections;
- large, greasy poos that are hard to flush, constipation, tummy pain or bloating;
- slow growth in children, or weight loss in adults;
- very salty sweat.
Some people have a milder form that does not show until the teenage years or early adulthood.
How doctors find out
All babies are checked for cystic fibrosis with the newborn blood spot test. If it suggests CF, a sweat test measures the salt in the sweat, which is usually high in CF. Older children and adults have a blood test and then a sweat test. Relatives of someone with CF, and partners of carriers, can have a test to see if they are carriers.
Current treatment
Care from a specialist CF team combines CFTR modulator medicines, airway-clearing medicines and physiotherapy, antibiotics for infections and a high-energy diet, with a lung transplant for some.
Will it get worse?
CF needs care for life and can shorten life. Over time it can lead to lung damage and other problems such as diabetes, liver disease, weak bones and difficulty having children, and many of these can be treated. Thanks to newer treatments many symptoms can be managed, and many people diagnosed today are expected to live well past middle age.
Medicines: what helps, and what to watch for
CFTR modulators are medicines that lessen the effect of the altered gene, so the lungs work better. Other medicines open up the airways or help clear mucus, antibiotics treat infections, and steroids calm swelling in the airways. Devices such as inhalers and specially designed masks can help with breathing and clearing mucus.
Good to know:
- you are cared for by a CF team, usually based at a larger hospital, with specialist doctors and nurses, a physiotherapist and a dietitian;
Exercise and therapy help too
- a physiotherapist can teach you ways to improve your breathing and posture, which helps clear mucus from your lungs;
- staying active also helps clear mucus;
A lung transplant, for some people
If other treatments stop working, some people may in time need a lung transplant. It is not suitable for everyone.
Is there a cure?
Not yet. Treatments have improved greatly in recent years, and gene editing shows promise.
Median survival
Median survival age at birth about 46 years (males) and 41 years (females), UK data 2011–2015
Measured in: People in the UK Cystic Fibrosis Registry, 2011–2015 (10,428 people); survival age counted from birth
The figures behind it
UK Cystic Fibrosis Registry data, 2011–2015 (10,428 people, 602 deaths): median survival age at birth 46 years for males and 41 years for females with two copies of F508del, similar for others diagnosed at birth. If mortality keeps improving at the same rate, the projection is 65 (males) and 56 (females).
Sources
Written in plain words by Frontlight from these pages: